• Explore /
  • Poster
  • / Randomized trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks vs. 2 weeks (SHORTER).

Randomized trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks vs. 2 weeks (SHORTER).

Abstract Poster

Authors

Ariel E. E. Marciscano

Ariel E. E. Marciscano

Weill Cornell Medical College, New York, NY

Ariel E. E. Marciscano , Xi K. Zhou , Christopher Barbieri , Jim C. Hu , Douglas Scherr , Sydney Wolfe , Silvia Formenti , Jones T. Nauseef , Cora N. Sternberg , Ana M. Molina , David M. Nanus , Scott T. Tagawa , Himanshu Nagar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04422132

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr TPS400)

DOI

10.1200/JCO.2023.41.6_suppl.TPS400

Abstract #

TPS400

Poster Bd #

R4

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Randomized trial of five or two MRI-guided adaptive radiotherapy treatments for prostate cancer (FORT).

Randomized trial of five or two MRI-guided adaptive radiotherapy treatments for prostate cancer (FORT).

First Author: Ariel E. E. Marciscano

First Author: Aneesh Dhar

First Author: Abhishek Kumar

First Author: Clayton P Smith